ea0025p253 | Pituitary | SFEBES2011
Clarke Holly
, Jayasena Channa
, Comninos Alexander
, Donaldson Mandy
, Meeran Karim
, Dhillo Waljit
Background: Patients with acromegaly require lifetime monitoring due to the excess mortality and morbidity associated with untreated disease, and the propensity for disease relapse following treatment. There is controversy whether GH or insulin-like growth factor 1 (IGF1), better predicts the onset of cardiovascular complications such as cardiomyopathy and ischaemic heart disease (IHD) in acromegalic patients.Aim: To examine associations of overall GH an...